Guimber et al., 2010 - Google Patents
Effect of multifibre mixture with prebiotic components on bifidobacteria and stool pH in tube-fed childrenGuimber et al., 2010
View PDF- Document ID
- 8950101261210757673
- Author
- Guimber D
- Bourgois B
- Beghin L
- Neuville S
- Pernes P
- Amor K
- Goedhart A
- Sijben J
- Knol J
- Gottrand F
- Publication year
- Publication venue
- British journal of nutrition
External Links
Snippet
The objective of the present study was to evaluate the effect of a paediatric tube feed supplemented with a multifibre mixture on the gut microbiota and nutritional and micronutrient status of children on long-term enteral nutrition (EN). A randomised, controlled …
- 230000000694 effects 0 title abstract description 27
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11833165B2 (en) | Synthetic composition and method for treating irritable bowel syndrome | |
| US11529364B2 (en) | Synthetic composition for treating metabolic disorders | |
| Kalman et al. | A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms | |
| Hunter et al. | Controlled trial of oligofructose in the management of irritable bowel syndrome | |
| Jung et al. | Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: a randomized, double-blind clinical trial | |
| Ramnani et al. | Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study | |
| Persson et al. | Nutritional supplementation and dietary advice in geriatric patients at risk of malnutrition | |
| Zaharoni et al. | Probiotics improve bowel movements in hospitalized elderly patients—The proage study | |
| ES2938355T3 (en) | Composition comprising HMOS for the treatment of non-infectious diarrhea | |
| CN108348535B (en) | Synthetic compositions and methods for modulating brain function and behavior | |
| Rezaei et al. | The effect of probiotic yogurt on blood glucose and cardiovascular biomarkers in patients with type II diabetes: a randomized controlled trial | |
| KR20170129718A (en) | A probiotic composition comprising at least bifidobacterium bifidum W23 and capable of controlling intestinal barrier function | |
| Tabbers et al. | Constipation in children | |
| CN111902155B (en) | Bifidobacterium longum NCIMB 41676 | |
| Guimber et al. | Effect of multifibre mixture with prebiotic components on bifidobacteria and stool pH in tube-fed children | |
| Žaja et al. | The role of L. reuteri DSM17938 in nutritional recovery and treatment of constipation in children and adolescents with anorexia nervosa-a randomized, double blind, placebo controlled study | |
| EP3452051B1 (en) | Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain | |
| Deng et al. | Probiotics for preventing gestational diabetes in overweight or obese pregnant women: A review | |
| CN112770749A (en) | Application of combination of bifidobacterium and berberine in treating pre-diabetes and type 2 diabetes | |
| Rasmussen et al. | Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: A phase I, randomized, double-blind, controlled human trial | |
| US20200138838A1 (en) | Composition comprising hmss/hmos and use thereof | |
| Borges et al. | Effects of Polydextrose Supplementation on Intestinal Function in Hemodialysis Patients: A Double-Blind, Randomized, Placebo-Controlled Trial | |
| US20230338403A1 (en) | Composition comprising 2'-fl and dfl for use in a method for reducing pain | |
| WO2021111422A1 (en) | Composition comprising 2'-fl and dfl for use in a method for reducing pain | |
| Snustad et al. | Dietary fiber in hospitalized geriatric patients: too soft a solution for too hard a problem? |